FilingReader Intelligence

Xuerong Biotech gets $8.4m loan backing amid ownership shift

March 20, 2025 at 05:06 AM UTCBy FilingReader AI

Shanghai Xuerong Biotechnology (SZSE:300511) announced it will receive loans totaling 60 million RMB (approximately $8.4 million USD) from its new and old controlling shareholders, Shanghai Wanzi Qianhong Intelligent Technology and Chairman Yang Yongping, respectively. Wanzi Qianhong will provide 40 million RMB, while Yang Yongping will provide 20 million RMB. These loans are aimed at supporting the company's business development and meeting its working capital needs, with interest rates no higher than prevailing bank loan rates. This financial backing comes as Yang Yongping is transferring control of the company to Wanzi Qianhong, pending Shenzhen Stock Exchange compliance confirmation, via a share transfer and voting rights delegation agreement. The loans do not require any guarantees, mortgages or pledges from Xuerong, and can be drawn down in tranches. The loan agreement with Yang Yongping supersedes a previous agreement and will be valid for one year. Additionally, Yang Yongping previously provided 9 million RMB in interest-free loans earlier this year.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Shanghai Xuerong Bio-Technology publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →